High-Risk Subset of CLL Patients Shows Benefit in Phase II Trial

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

The White House Office of Management and Budget has published a “Regulation for Federal Financial Assistance,” a proposed rule that seeks to fundamentally redraw the ground rules for all federally funded research. On the other side are America’s scientists who aren’t just crying foul—they are readying for a political fight.

June 12, 2026

Vol.52 No.23

By Jacquelyn Cobb

Capitol Hill

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

On June 9, the House Appropriations Committee passed its version of the fiscal year 2027 spending bill for Labor, Health and Human Services, and Education.

June 12, 2026

Vol.52 No.23

By Paul Goldberg

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Last week, Wafik El-Deiry, a cancer researcher at Brown University, showed up at a Senate hearing to talk about what he sees as dangers of the COVID-19 vaccine.

June 12, 2026

Vol.52 No.23

By Paul Goldberg

Clinical Trials & Tribulations

Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy

In 1989, I stood in front of the AIDS Memorial Quilt on a hot summer afternoon on the National Mall in Washington DC.

June 12, 2026

Vol.52 No.23

By Peter F. Garrett

Survivorship begins at diagnosis—cancer care system must recognize this

The oncology field is confronting three forces simultaneously.

NIH calls for comment on proposal to limit the number of RPGs per PI

NIH has published a request for information on its proposed policy that would cap the number of research project grants, or RPGs, for which an individual can simultaneously serve as principal investigator or multi-principal investigator.

June 12, 2026

Vol.52 No.23

By Jacquelyn Cobb

High-Risk Subset of CLL Patients Shows Benefit in Phase II Trial

YOU MAY BE INTERESTED IN

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy

Survivorship begins at diagnosis—cancer care system must recognize this

NIH calls for comment on proposal to limit the number of RPGs per PI

Renew today!

Subscriber content

Never miss an issue!

Login

High-Risk Subset of CLL Patients Shows Benefit in Phase II Trial

YOU MAY BE INTERESTED IN

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick labThe job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy

Survivorship begins at diagnosis—cancer care system must recognize this

NIH calls for comment on proposal to limit the number of RPGs per PI

Never miss an issue!

Login

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded